Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2102-2108
Published online before print April 14, 2003, doi: 10.1161/01.CIR.0000065220.70220.F7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/16/2102    most recent
01.CIR.0000065220.70220.F7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.-H.
Right arrow Articles by Yang, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.-H.
Right arrow Articles by Yang, C.-Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Cholesterol
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Apoptosis
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Growth factors/cytokines

(Circulation. 2003;107:2102.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription

Chu-Huang Chen, MD, PhD; Tao Jiang, PhD; Jun-Hai Yang, PhD; Wei Jiang, MD; Jonathan Lu, MD; Gopal K. Marathe, PhD; Henry J. Pownall, PhD; Christie M. Ballantyne, MD; Thomas M. McIntyre, PhD; Philip D. Henry, MD; Chao-Yuh Yang, PhD

From the Departments of Medicine (C.-H.C., T.J., W.J., J.L., H.J.P., C.M.B., P.D.H., C.-Y.Y.) and Ophthalmology (J.-H.Y.), Baylor College of Medicine, Houston, Tex, and the Department of Internal Medicine (G.K.M., T.M.M.), University of Utah, Salt Lake City.

Correspondence to Chu-Huang Chen, MD, PhD, MS A-601, Department of Medicine, Baylor College of Medicine, 6565 Fannin St, Houston, Texas 77030. E-mail cchen{at}bcm.tmc.edu

Background— Apoptosis of vascular endothelial cells (ECs) can be induced in vitro by experimentally modified LDL. Description of proapoptotic circulating lipoproteins may significantly enhance understanding of atherothrombosis pathophysiology.

Methods and Results— Fast protein liquid chromatography of LDL samples from 7 asymptomatic, hypercholesterolemic patients yielded subfractions L1–L5 in increasing electronegativity. L4 and L5 were not detectable or collectible in normolipidemic samples. In bovine aortic EC cultures, L5 induced marked apoptosis and L4 had a mild effect, whereas hypercholesterolemic or normolipidemic L1–L3 had negligible effects. Compared with copper-oxidized LDL, L5 was only mildly oxidized, although its propensity to form conjugated dienes in response to copper exceeded that of other subfractions. L5-induced apoptosis was associated with suppressed fibroblast growth factor 2 (FGF-2) transcription, as assessed by nuclear run-on analysis. Degrading platelet-activating factor (PAF)-like lipids in L5 by a recombinant PAF acetylhydrolase prevented both FGF-2 downregulation and apoptosis. Furthermore, the ability of L5 lipid extract to induce calcium influx into neutrophils was lost after pretreatment of the extract with PAF acetylhydrolase. FGF-2 supplementation, PAF receptor (PAFR) blockade with WEB-2086, and inactivation of PAFR-coupled Gi protein with pertussis toxin all effectively attenuated L5-induced apoptosis.

Conclusions— Our findings indicate that a highly electronegative, mildly oxidized LDL subfraction present in human hypercholesterolemic but not normolipidemic plasma can induce apoptosis in cultured ECs. The evidence that a freshly isolated LDL species modulates transcription of FGF-2 may provide a physiological insight into the mechanism of vascular EC apoptosis in hypercholesterolemia.


Key Words: lipoproteins • endothelium • apoptosis • growth substances • phospholipids




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. A. Medina
Hyperhomocysteinemia and Occlusive Vascular Disease: An Emergent Role for Fibroblast Growth Factor 2
Circ. Res., April 25, 2008; 102(8): 869 - 870.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee
Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Circ. Res., April 25, 2008; 102(8): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Tang, J. Lu, J. P. Walterscheid, H.-H. Chen, D. A. Engler, T. Sawamura, P.-Y. Chang, H. J. Safi, C.-Y. Yang, and C.-H. Chen
Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1
J. Lipid Res., January 1, 2008; 49(1): 33 - 47.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al.
Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation
Diabetes, January 1, 2008; 57(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Cheng, R. Cui, C.-H. Chen, and J. Du
Oxidized Low-Density Lipoprotein Stimulates p53-Dependent Activation of Proapoptotic Bax Leading to Apoptosis of Differentiated Endothelial Progenitor Cells
Endocrinology, May 1, 2007; 148(5): 2085 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-H. Chen and J. P. Walterscheid
Plaque Angiogenesis Versus Compensatory Arteriogenesis in Atherosclerosis
Circ. Res., October 13, 2006; 99(8): 787 - 789.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. K. Marathe, C. Johnson, S. D. Billings, M. D. Southall, Y. Pei, D. Spandau, R. C. Murphy, G. A. Zimmerman, T. M. McIntyre, and J. B. Travers
Ultraviolet B Radiation Generates Platelet-activating Factor-like Phospholipids underlying Cutaneous Damage
J. Biol. Chem., October 21, 2005; 280(42): 35448 - 35457.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. W. Choi and S. K. Kim
Relationships of Soluble APO-1 (Fas/CD95) Concentrations, Obesity, and Serum Lipid Parameters in Healthy Adults
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 290 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Bonin, S. D. Ryan, L. Migahed, F. Mo, J. Lallier, D. J. Franks, H. Arai, and S. A. L. Bennett
Anti-apoptotic Actions of the Platelet-activating Factor Acetylhydrolase I {alpha}2 Catalytic Subunit
J. Biol. Chem., December 10, 2004; 279(50): 52425 - 52436.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P.-Y. Chang, S.-C. Lu, T.-C. Su, S.-F. Chou, W.-H. Huang, J. D. Morrisett, C.-H. Chen, C.-S. Liau, and Y.-T. Lee
Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation
J. Lipid Res., November 1, 2004; 45(11): 2116 - 2122.
[Abstract] [Full Text] [PDF]